Use an evidence-aware requirements diff: keep declaration coverage, mechanical comparison, evidence linkage and human decisions separate, then expose every gap against exact versions.

Build a requirements diff, not a laboratory recommender

A study request describes what a sponsor needs. A capability declaration describes what a laboratory says it can support, under stated conditions and limitations. Software can compare those two records. It can find absent fields, exact identifier differences, values outside declared ranges, conflicting statements and evidence links. It cannot turn those observations into a reliable ranking of laboratories or a prediction that the study will succeed.

The useful output is therefore a requirements diff. Each row shows the requested value, the laboratory-declared value, the comparison rule, the evidence attached and the person who must resolve any difference. Avoid a blended fit score: a high coverage percentage can hide one consequential conflict, and a complete declaration can still be scientifically unsuitable or unsupported.

  • Compare one exact study-request version with one exact declaration version
  • Show both supplied values beside every result
  • Name the deterministic rule that produced the result
  • Keep missing, conflicting and out-of-range findings visible
  • Never output trusted, qualified, equivalent, validated or ready

Lock the scope before comparing individual fields

Begin with intended use, research objective, exact legal entity, physical site, responsible contacts, delegated phases and subcontracting constraints. A capability statement for another site or service cannot be carried across automatically. The declaration should also state excluded uses and conditions so that a sponsor does not interpret a bounded service statement as a promise about every possible study.

NIST's NVLAP procedures illustrate why accreditation evidence is tied to a specific laboratory identity, site and assessed scope. NATA's R&D testing material similarly emphasises a clearly defined request and agreed objective within its accreditation context. SingularCell can preserve those boundaries, but it does not assess competence or determine whether accreditation applies to the proposed work.

  • Research objective and decision context
  • Legal entity and exact physical site
  • Responsible sponsor and laboratory roles
  • Subcontracted sites or delegated phases
  • Declared exclusions, limitations and applicable-use boundaries

Compare the biological and measurement context explicitly

Assay names are too coarse for a useful comparison. Record the test material, formulation or construct reference, species, exact cell line or model, source, passage or state, authentication evidence, sample type and matrix. Then compare the measurand, readout, units, timepoints, method version, technique, platform, instrument, software, acquisition settings and analysis pipeline.

NIH notes that key biological resources can differ across laboratories or over time, while NIST's cell-characterisation work emphasises process conditions, measurement performance and uncertainty. Software may detect an identical controlled identifier or a difference in supplied context. A qualified person must decide whether two terms, biological states, methods or operational definitions are scientifically compatible.

  • Exact material and biological-resource identity
  • Sample type, matrix, volume, condition and storage window
  • Operational measurand, readout, unit and timepoint
  • Method, technique, platform and configuration versions
  • Known limitations and measurement-performance evidence

Use neutral mechanical comparison results

Deterministic results should describe only the operation performed. Useful states include identical identifier, identical declared value, requested value inside or outside a declared numeric range, declared set includes request, version difference, context difference, terminology mapping required, insufficient information and conflict. Numeric containment is valid only when units, matrix, method and stated conditions are compatible.

Do not call these results a match, pass or proof of capability. An identical method identifier says nothing about execution quality. A requested value inside a laboratory-supplied range does not show that the range is credible or achievable. A language-model terminology mapping is a proposed correspondence, not scientific equivalence, and should remain review-required until a named person accepts it for a bounded scope.

  • Normalize only non-semantic formatting before equality checks
  • Convert only compatible units for the same measurand and context
  • Flag version and context differences separately
  • Send terminology mappings to human review
  • Return insufficient information instead of guessing

Keep declarations, evidence and accreditation separate

A declaration is what the laboratory supplied. Evidence is a record linked to that declaration. Accreditation is a third-party assessment with an exact issuer, site, scope, status and limitations. Store these as separate facts. A certificate or logo without its scope cannot establish that the requested activity, material, method or range is included, and absence from a public scope does not prove that the laboratory lacks an unaccredited capability.

For each evidence record, capture its type, issuer, site, activity, method, version, date, status, expiry, limitations, source location and relationship to the field. Label laboratory-supplied evidence as such. A linked record is not automatically authentic, current, sufficient or applicable. Those are distinct checks and, where judgment is required, distinct human decisions.

  • Identify the evidence issuer and stable record reference
  • Bind it to the exact site, activity, method and limitations
  • Record issue, effective, expiry and observed-status dates
  • Distinguish laboratory-supplied from independently retrieved evidence
  • Report not confirmed rather than making an unsupported negative claim

Flag consequential differences without deciding equivalence

FDA's ICH M10 guidance provides a regulated bioanalytical example of changes that can matter: analytical site, detection platform, sample processing, calibration range, matrix or species, storage and critical-reagent lots. It also treats cross-validation as evidence for comparing specified methods or laboratories within its scope. Those examples are prompts for careful review, not universal rules for cell-based research.

When such a difference appears, SingularCell should issue a specific discrepancy and request qualified assessment. It must not infer that bridging, verification or cross-validation is required, sufficient or complete. The decision depends on the exact study, method, intended use and evidence. A documentation system can ensure the question is not lost; it cannot answer the scientific question by itself.

  • Material, cell-state or matrix difference
  • Method, site, platform or software difference
  • Range or measurement-performance gap
  • Control, reference-material or quality-monitoring difference
  • Evidence-scope or evidence-status difference

Return a discrepancy queue with accountable owners

Every unresolved row should identify the discrepancy type, request value, declaration value, evidence reference, comparison rule and required decision owner. Separate scientific review, measurement review, quality review, legal or regulatory review and commercial or operational clarification. This prevents a project manager's scheduling approval from being misread as scientific acceptance, or a scientist's method opinion from becoming a compliance determination.

The final summary should report declaration coverage, mechanically aligned fields, terminology or scientific-review fields, and missing, conflicting or out-of-scope fields as separate counts. It should repeat the boundary before any conclusion: the comparison does not determine laboratory quality, competence, trustworthiness, scientific suitability, method or site equivalence, validated transfer, compliance or expected study outcome.

  • Assign every discrepancy to a named decision role
  • Bind each decision to exact request and declaration versions
  • Record rationale, evidence, date, scope and limitations
  • Do not let a blended score hide a blocking discrepancy
  • Require explicit human disposition before the handoff advances

Primary sources

Material claims were checked against the organisations responsible for the guidance or measurement work.

  1. NATA — ISO/IEC 17025 Annex: Testing in support of R&D ↗National Association of Testing Authorities, Australia · Bounded request definition, method description, samples, parameters, limitations, quality controls, data, retention and reporting in its accreditation context.
  2. NIST — NVLAP Procedures and General Requirements ↗National Institute of Standards and Technology · Binding accreditation evidence to an exact laboratory identity, site, dates, assessed scope, methods, ranges and limitations.
  3. FDA — ICH M10 Bioanalytical Method Validation and Study Sample Analysis ↗United States Food and Drug Administration · Regulated-context examples of consequential method, site, platform, matrix, storage, reagent and cross-laboratory differences.
  4. NIH — Authentication of Key Biological and/or Chemical Resources ↗National Institutes of Health · Study-specific identity and authentication planning for key resources that can differ across laboratories or over time.
  5. NIST — Building Measurement Confidence in Cell Characterization ↗National Institute of Standards and Technology · Measurement context, process conditions, reproducibility, uncertainty, detection range and fit-for-purpose evidence.

Limitations

  • This guide compares supplied declarations and evidence; it does not assess laboratory competence, quality, qualification, trustworthiness or expected performance.
  • Accreditation applies only to the exact issuer, legal entity, site, activity, scope, status and limitations shown; SingularCell does not determine accreditation or compliance.
  • FDA M10 examples are bounded to its regulated bioanalytical scope and do not prescribe validation or equivalence requirements for an ordinary cell-based research study.
  • Exact identifiers, range containment, evidence links and terminology mappings cannot establish scientific suitability, method transfer or laboratory equivalence.

Related SingularCell guidance

See the handoff as a working system.

Explore one synthetic study from research question through capability comparison, returned results and review-required evidence.

Explore the synthetic comparison →Discuss a design-partner workflow